CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DaebongLS Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DaebongLS Co Ltd
Daebong LS Songdo R&D Center
101 Songdo Mirae-ro, Yeonsu-gu
Phone: +82 327128800p:+82 327128800 INCHEON, 21989  South Korea Ticker: 078140078140
Business Summary
DaebongLS Co Ltd is a Korea-based company primarily engaged in the manufacture of pharmaceutical and cosmetic ingredients. The Company operates its business through two segments. The Pharmaceutical Active Ingredient Business segment provides active pharmaceutical ingredients for respiratory treatments, hypertension treatments, and digestive system treatments. The Cosmetic Material Business segment manufactures and sells natural and functional cosmetic ingredients. In addition, the Company provides testing services for materials used on the skin and engages in real estate leasing business. The Company sells its products in domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2844 Perfumes, cosmetics, and other toilet preparations
8734 Testing laboratories
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Co-Chief Executive Officer Jong HoPark 52 3/27/2013
Co-Chief Executive Officer, Director Jin OhPark 54 3/27/2013
Chief Financial Officer, Director Chang WuSon 45 12/31/2005 12/31/2005
4 additional Officers and Directors records available in full report.

Business Names
Business Name
078140
Daebong LS Co., Ltd.

General Information
Number of Employees: 138 (As of 12/31/2025)
Outstanding Shares: 10,948,169 (As of 12/31/2025)
Shareholders: 10,909
Stock Exchange: KDQ
Fax Number: +82 328178808


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 31, 2026